OM DENNE EPISODE
In this episode of Communicable, hosts Annie Joseph and Josh Nosanchuk welcome Neil Stone and Jeniel Nett to discuss new and emerging antifungal treatments, including ibrexafungerp, rezafungin and olorofim, among others. The panel reviews the evidence behind these drugs, their clinical indications and potential uses, as well as their limitations, including accessibility. The conversation also covers exciting developments in the antifungal pipeline, remaining challenges, and priorities for future research.
Further reading
- WHO fungal priority pathogens list. 2022.
- Schwebke JR. Ibrexafungerp Versus Placebo for Vulvovaginal Candidiasis Treatment: A Phase 3, Randomized, Controlled Superiority Trial (VANISH 303). Clin Infect Dis 2022. DOI: 10.1093/cid/ciab750.
- Thompson GR III, et al. Rezafungin Versus Caspofungin in a Phase 2, Randomized, Double-blind Study for the Treatment of Candidemia and Invasive Candidiasis: The STRIVE Trial. Clin Infect Dis 2021. DOI: 10.1093/cid/ciaa1380.
- Thompson GR III, et al. Rezafungin versus caspofungin for treatment of candidaemia and invasive candidiasis (ReSTORE): a multicentre, double-blind, double-dummy, randomised phase 3 trial. Lancet 2023. DOI: 10.1016/S0140-6736(22)02324-8.
- Donovan FM, et al. Olorofim in Treatment of Patients With Poorly Controlled Disseminated Coccidioidomycosis: A Single-Group, Open-Label, Phase 2b, Multicenter Study. Ann Intern Med 2026. DOI: 10.7326/ANNALS-26-00103.
Engelsk
USA
I DENNE EPISODE
UDSKRIFT 🔗
Communicable 067: Antifungal pipeline
===
[00:00:00]
Annie: Hello, and welcome back to Communicable, the podcast brought to you by CMI Communications, ESCMID's open access journal covering infectious diseases and clinical microbiology. My name is Annie Joseph. I'm a clinical microbiologist at Nottingham University Hospitals NHS Trust in the UK and associate editor at CMI Comms.
I'm really happy to be joined today by my co-host, Josh Nosanchuk, fellow editor at CMI Comms, infectious diseases …
===
[00:00:00]
Annie: Hello, and welcome back to Communicable, the podcast brought to you by CMI Communications, ESCMID's open access journal covering infectious diseases and clinical microbiology. My name is Annie Joseph. I'm a clinical microbiologist at Nottingham University Hospitals NHS Trust in the UK and associate editor at CMI Comms.
I'm really happy to be joined today by my co-host, Josh Nosanchuk, fellow editor at CMI Comms, infectious diseases …
SØG BLANDT TIDLIGERE EPISODER
Søg efter gamle afsnit af Communicable.
Ansvarsfraskrivelse: Podcasten og kunstværket, der er indlejret på denne side, er fra CMI Communications, som tilhører dens ejer og ikke er tilknyttet eller godkendt af Listen Notes, Inc.
REDIG
Tak fordi du hjælper med at holde podcast-databasen opdateret.